Tier 1 — highest
Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep
Magnesium research
2010
23(4):158-68
Bibliography
- PubMed
- PMID 21199787
- Funding
- Funding is not specified in the indexed abstract or accessible funding metadata. Consult the original publication for the declaration.
- Competing interests
- A competing-interest declaration is not available in the indexed abstract or accessible disclosure metadata.
Study snapshot
| Design | Randomized controlled clinical trial |
|---|---|
| Model | Human participants |
| Sample | 100 adults over 51 randomized; 96 completed |
| Intervention | 320 mg/day elemental magnesium as citrate or placebo |
| Duration | 7 weeks |
| Endpoints | Sleep quality; Magnesium status; C-reactive protein |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
Biohack Blueprint Research
